A1IZ3

5-[2,4-bis(fluoranyl)phenoxy]-2-(cyclohexylmethyl)-~{N}-[2-[(3~{R})-3-(methoxymethyl)piperidin-1-yl]ethyl]indazole-6-carboxamide

Created:	2025-01-28
Last modified:	2025-08-20

Find Related PDB Entry
1 entries where A1IZ3 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	77
Chiral Atom Count	1
Bond Count	81
Aromatic Bond Count	16

2D diagram of A1IZ3

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	5-[2,4-bis(fluoranyl)phenoxy]-2-(cyclohexylmethyl)-~{N}-[2-[(3~{R})-3-(methoxymethyl)piperidin-1-yl]ethyl]indazole-6-carboxamide
Synonyms	2-(cyclohexylmethyl)-5-(2,4-difluorophenoxy)-N-(2-(3-(methoxymethyl)piperidin-1-yl)ethyl)-2H-indazole-6-carboxamide
Systematic Name (OpenEye OEToolkits)	5-[2,4-bis(fluoranyl)phenoxy]-2-(cyclohexylmethyl)-~{N}-[2-[(3~{R})-3-(methoxymethyl)piperidin-1-yl]ethyl]indazole-6-carboxamide
Formula	C₃₀ H₃₈ F₂ N₄ O₃
Molecular Weight	540.645
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	COC[CH]1CCCN(CCNC(=O)c2cc3nn(CC4CCCCC4)cc3cc2Oc5ccc(F)cc5F)C1
SMILES	OpenEye OEToolkits	2.0.7	COCC1CCCN(C1)CCNC(=O)c2cc3c(cc2Oc4ccc(cc4F)F)cn(n3)CC5CCCCC5
Canonical SMILES	CACTVS	3.385	COC[C@@H]1CCCN(CCNC(=O)c2cc3nn(CC4CCCCC4)cc3cc2Oc5ccc(F)cc5F)C1
Canonical SMILES	OpenEye OEToolkits	2.0.7	COC[C@@H]1CCCN(C1)CCNC(=O)c2cc3c(cc2Oc4ccc(cc4F)F)cn(n3)CC5CCCCC5
InChI	InChI	1.06	InChI=1S/C30H38F2N4O3/c1-38-20-22-8-5-12-35(17-22)13-11-33-30(37)25-16-27-23(19-36(34-27)18-21-6-3-2-4-7-21)14-29(25)39-28-10-9-24(31)15-26(28)32/h9-10,14-16,19,21-22H,2-8,11-13,17-18,20H2,1H3,(H,33,37)
InChIKey	InChI	1.06	OJJHRKPNNTZEQJ-UHFFFAOYSA-N

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.